| Amyotrophic lateral sclerosis MC Kiernan, S Vucic, BC Cheah, MR Turner, A Eisen, O Hardiman, ... The lancet 377 (9769), 942-955, 2011 | 2810 | 2011 |
| Chemotherapy‐induced peripheral neurotoxicity: a critical analysis SB Park, D Goldstein, AV Krishnan, CSY Lin, ML Friedlander, J Cassidy, ... CA: a cancer journal for clinicians 63 (6), 419-437, 2013 | 686 | 2013 |
| Clinical diagnosis and management of amyotrophic lateral sclerosis O Hardiman, LH Van Den Berg, MC Kiernan Nature reviews neurology 7 (11), 639-649, 2011 | 685 | 2011 |
| Controversies and priorities in amyotrophic lateral sclerosis MR Turner, O Hardiman, M Benatar, BR Brooks, A Chio, M De Carvalho, ... The Lancet Neurology 12 (3), 310-322, 2013 | 592 | 2013 |
| Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016 | 529 | 2016 |
| Biomarkers in amyotrophic lateral sclerosis MR Turner, MC Kiernan, PN Leigh, K Talbot The Lancet Neurology 8 (1), 94-109, 2009 | 495 | 2009 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1268-1283. e6, 2018 | 483 | 2018 |
| Multiple measures of axonal excitability: a new approach in clinical testing MC Kiernan, D Burke, KV Andersen, H Bostock Muscle & Nerve: Official Journal of the American Association of …, 2000 | 482 | 2000 |
| Excitability of human axons D Burke, MC Kiernan, H Bostock Clinical neurophysiology 112 (9), 1575-1585, 2001 | 476 | 2001 |
| Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis S Vucic, GA Nicholson, MC Kiernan Brain 131 (6), 1540-1550, 2008 | 464 | 2008 |
| Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype EK Mathey, SB Park, RAC Hughes, JD Pollard, PJ Armati, MH Barnett, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (9), 973-985, 2015 | 407 | 2015 |
| Strength-duration properties of human peripheral nerve I Mogyoros, MC Kiernan, D Burke Brain 119 (2), 439-447, 1996 | 401 | 1996 |
| Amyotrophic lateral sclerosis: moving towards a new classification system A Al-Chalabi, O Hardiman, MC Kiernan, A Chiň, B Rix-Brooks, ... The Lancet Neurology 15 (11), 1182-1194, 2016 | 385 | 2016 |
| Guillain-Barré syndrome: an update S Vucic, MC Kiernan, DR Cornblath Journal of clinical neuroscience 16 (6), 733-741, 2009 | 378 | 2009 |
| Motor neuron dysfunction in frontotemporal dementia JR Burrell, MC Kiernan, S Vucic, JR Hodges Brain 134 (9), 2582-2594, 2011 | 336 | 2011 |
| The frontotemporal dementia-motor neuron disease continuum JR Burrell, GM Halliday, JJ Kril, LM Ittner, J Götz, MC Kiernan, JR Hodges The Lancet 388 (10047), 919-931, 2016 | 324 | 2016 |
| Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease S Vucic, MC Kiernan Brain 129 (9), 2436-2446, 2006 | 322 | 2006 |
| Effects of membrane polarization and ischaemia on the excitability properties of human motor axons MC Kiernan, H Bostock Brain 123 (12), 2542-2551, 2000 | 316 | 2000 |
| Riluzole, neuroprotection and amyotrophic lateral sclerosis BC Cheah, S Vucic, AV Krishnan, MC Kiernan Current medicinal chemistry 17 (18), 1942-1959, 2010 | 306 | 2010 |
| Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights S Vucic, U Ziemann, A Eisen, M Hallett, MC Kiernan Journal of Neurology, Neurosurgery & Psychiatry 84 (10), 1161-1170, 2013 | 278 | 2013 |
Steve VucicProfessor of Neurology, University of SydneyVerified email at sydney.edu.au
